Dermata Therapeutics, Inc. Warrant (DRMAW) Financials
DRMAW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 7.3 million | 916817 |
| 2023-06-30 | 8.7 million | 682862 |
| 2023-03-31 | 9.3 million | 1.2 million |
| 2022-12-31 | 6.9 million | 922634 |
DRMAW Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.8 million | 131177 |
| 2023-06-30 | -1.8 million | 131177 |
| 2023-03-31 | -1.6 million | 131260 |
| 2022-12-31 | -1.8 million | 220890 |
DRMAW Net Income
No data available :(
DRMAW Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 6.6 million | - | - |
| 2023-06-30 | 8.4 million | - | - |
| 2023-03-31 | 8.8 million | - | - |
| 2022-12-31 | 6.2 million | - | - |
DRMAW Shares Outstanding
DRMAW Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 902977 | 909001 | - |
| 2023-06-30 | - | 838931 | 893483 | - |
| 2023-03-31 | - | 1.2 million | 1.1 million | - |
| 2022-12-31 | - | 889355 | 822334 | - |
DRMAW Cost of Revenue
No data available :(
DRMAW
Price: $0.02
52 week price:
Earnings Per Share: -2.16 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 203
Market Capitalization: 1.3 million